<p>Aging is characterized by chronic inflammation, oxidative stress and progressive cellular senescence. Thymoquinone (TQ), a major bioactive constituent of <i>Nigella sativa</i> oil<i>,</i> has attracted considerable research interest due to its anti-inflammatory and anti-oxidative properties. However, its integrated effects using widely used aging markers i.e. senescence associated beta-galactosidase (SA-<i>β</i>-gal) and lipofuscin granules, in D-galactose (D-gal) induced premature aging models has not been addressed yet. This study investigates the potential of TQ in attenuating D-gal induced premature aging and its associated phenotypes through its anti-inflammatory and anti-oxidative properties in a mouse model. Male Swiss Webster albino mice were divided into five groups: control, D-gal (600&#xa0;mg/kg) to induce premature aging and three TQ treatment groups (5, 10 and 20&#xa0;mg/kg) with D-gal for eight weeks. SA-<i>β</i>-gal activity and lipofuscin accumulation were estimated for aging, IL-6, IL-8, E-selectin, ICAM-1 as inflammatory mediators, malondialdehyde (MDA) and total antioxidant capacity (TAC) for oxidative stress, while total nitric oxide metabolites (NOx) to evaluate nitric oxide bioavailability. D-gal induced premature aging was evidenced by increased SA-<i>β</i>-gal expression and lipofuscin granules accumulation in liver and kidney tissues. TQ significantly attenuated these alterations by down regulating IL-6, IL-8, E-selectin and ICAM-1, restoring anti-oxidant balance by decreasing MDA, restoring TAC and NOx with TQ 20&#xa0;mg/kg showing the strongest effect. Using SA-<i>β</i>-gal and lipofuscin as widely used aging markers, our findings provide compelling evidence in vivo that TQ exhibit anti-aging effects by modulating inflammation, restoring NOx balance and curbing oxidative stress, highlighting its potential as therapeutic agent for age-related diseases.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Anti-inflammatory and anti-oxidative properties of thymoquinone attenuate D-galactose induced premature aging-associated alterations in mice

  • Fiza Malik,
  • Shafaat Yar Khan,
  • Ambreen Khalid,
  • Muhammad Khalid Mukhtar,
  • Muhammad Awais,
  • Ahmad Khan,
  • Mahnoor Arshad,
  • Hafiz Muhammad Mazhar Asjad,
  • Ezzat M. Awad

摘要

Aging is characterized by chronic inflammation, oxidative stress and progressive cellular senescence. Thymoquinone (TQ), a major bioactive constituent of Nigella sativa oil, has attracted considerable research interest due to its anti-inflammatory and anti-oxidative properties. However, its integrated effects using widely used aging markers i.e. senescence associated beta-galactosidase (SA-β-gal) and lipofuscin granules, in D-galactose (D-gal) induced premature aging models has not been addressed yet. This study investigates the potential of TQ in attenuating D-gal induced premature aging and its associated phenotypes through its anti-inflammatory and anti-oxidative properties in a mouse model. Male Swiss Webster albino mice were divided into five groups: control, D-gal (600 mg/kg) to induce premature aging and three TQ treatment groups (5, 10 and 20 mg/kg) with D-gal for eight weeks. SA-β-gal activity and lipofuscin accumulation were estimated for aging, IL-6, IL-8, E-selectin, ICAM-1 as inflammatory mediators, malondialdehyde (MDA) and total antioxidant capacity (TAC) for oxidative stress, while total nitric oxide metabolites (NOx) to evaluate nitric oxide bioavailability. D-gal induced premature aging was evidenced by increased SA-β-gal expression and lipofuscin granules accumulation in liver and kidney tissues. TQ significantly attenuated these alterations by down regulating IL-6, IL-8, E-selectin and ICAM-1, restoring anti-oxidant balance by decreasing MDA, restoring TAC and NOx with TQ 20 mg/kg showing the strongest effect. Using SA-β-gal and lipofuscin as widely used aging markers, our findings provide compelling evidence in vivo that TQ exhibit anti-aging effects by modulating inflammation, restoring NOx balance and curbing oxidative stress, highlighting its potential as therapeutic agent for age-related diseases.